Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence.

Sliepen K, Han BW, Bontjer I, Mooij P, Garces F, Behrens AJ, Rantalainen K, Kumar S, Sarkar A, Brouwer PJM, Hua Y, Tolazzi M, Schermer E, Torres JL, Ozorowski G, van der Woude P, de la Peña AT, van Breemen MJ, Camacho-Sánchez JM, Burger JA, Medina-Ramírez M, González N, Alcami J, LaBranche C, Scarlatti G, van Gils MJ, Crispin M, Montefiori DC, Ward AB, Koopman G, Moore JP, Shattock RJ, Bogers WM, Wilson IA, Sanders RW.

Nat Commun. 2019 May 29;10(1):2355. doi: 10.1038/s41467-019-10262-5.

2.

Influenza virus infection as well as immunization with DNA encoding haemagglutinin protein induces potent antibody-dependent phagocytosis (ADP) and monocyte infection-enhancing responses in macaques.

Koopman G, Mortier D, Michels S, Hofman S, Fagrouch Z, Remarque EJ, Verschoor EJ, Mooij P, Bogers WMJM.

J Gen Virol. 2019 May;100(5):738-751. doi: 10.1099/jgv.0.001251. Epub 2019 Mar 28.

PMID:
30920368
3.

Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza.

Mooij P, Grødeland G, Koopman G, Andersen TK, Mortier D, Nieuwenhuis IG, Verschoor EJ, Fagrouch Z, Bogers WM, Bogen B.

Vaccine. 2019 Feb 4;37(6):817-826. doi: 10.1016/j.vaccine.2018.12.049. Epub 2019 Jan 9.

4.

Workshop report: Experimental animal models for universal influenza vaccines.

D'Alessio F, Koopman G, Houard S, Remarque EJ, Stockhofe N, Engelhardt OG.

Vaccine. 2018 Nov 12;36(46):6895-6901. doi: 10.1016/j.vaccine.2018.10.024. Epub 2018 Oct 16.

PMID:
30340885
5.

Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.

van der Lubbe JEM, Huizingh J, Verspuij JWA, Tettero L, Schmit-Tillemans SPR, Mooij P, Mortier D, Koopman G, Bogers WMJM, Dekking L, Meijberg W, Kwaks T, Brandenburg B, Tolboom JTBM, Schuitemaker H, Roozendaal R, Kuipers H, Zahn RC.

NPJ Vaccines. 2018 Jul 3;3:25. doi: 10.1038/s41541-018-0063-7. eCollection 2018.

6.

EDiP: the Epitope Dilution Phenomenon. Lessons learnt from a malaria vaccine antigen and its applicability to polymorphic antigens.

Kusi KA, Faber BW, Koopman G, Remarque EJ.

Expert Rev Vaccines. 2018 Jan;17(1):13-21. doi: 10.1080/14760584.2018.1411198. Epub 2017 Dec 11.

PMID:
29224404
7.

Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.

Bogers WMJM, Barnett SW, Oostermeijer H, Nieuwenhuis IG, Beenhakker N, Mortier D, Mooij P, Koopman G, Remarque E, Martin G, Lai RP, Dey AK, Sun Y, Burke B, Ferrari G, Montefiori D, Martin L, Davis D, Srivastava I, Heeney JL.

J Virol. 2017 Sep 12;91(19). pii: e00811-17. doi: 10.1128/JVI.00811-17. Print 2017 Oct 1.

8.

Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.

Mothapo KM, Ten Oever J, Koopmans P, Stelma FF, Burm S, Bajramovic J, Verbeek MM, Rikkert MGO, Netea MG, Koopman G, van der Ven AJ.

J Neurovirol. 2017 Apr;23(2):250-259. doi: 10.1007/s13365-016-0495-7. Epub 2016 Nov 23.

PMID:
27882497
9.

Role of microbial translocation in soluble CD14 up-regulation in HIV-, but not in HCV-, infected chimpanzees.

Verstrepen BE, Nieuwenhuis IG, Mooij P, Verschoor EJ, Fagrouch ZC, Kondova I, Boonstra A, Koopman G.

J Gen Virol. 2016 Oct;97(10):2599-2607. doi: 10.1099/jgv.0.000577. Epub 2016 Aug 16.

PMID:
27534537
10.

Spontaneous and natural cytotoxicity receptor-mediated cytotoxicity are effector functions of distinct natural killer subsets in hepatitis C virus-infected chimpanzees.

Verstrepen BE, Nieuwenhuis IG, Mooij P, Bogers WM, Boonstra A, Koopman G.

Clin Exp Immunol. 2016 Jul;185(1):42-9. doi: 10.1111/cei.12774. Epub 2016 Apr 27.

11.

Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus.

Koopman G, Mooij P, Dekking L, Mortier D, Nieuwenhuis IG, van Heteren M, Kuipers H, Remarque EJ, Radošević K, Bogers WM.

J Virol. 2015 Nov 4;90(2):1023-33. doi: 10.1128/JVI.02757-15. Print 2016 Jan 15.

12.

Pandemic Swine-Origin H1N1 Influenza Virus Replicates to Higher Levels and Induces More Fever and Acute Inflammatory Cytokines in Cynomolgus versus Rhesus Monkeys and Can Replicate in Common Marmosets.

Mooij P, Koopman G, Mortier D, van Heteren M, Oostermeijer H, Fagrouch Z, de Laat R, Kobinger G, Li Y, Remarque EJ, Kondova I, Verschoor EJ, Bogers WM.

PLoS One. 2015 May 6;10(5):e0126132. doi: 10.1371/journal.pone.0126132. eCollection 2015.

13.

Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1.

Mooij P, Koopman G, Drijfhout JW, Nieuwenhuis IG, Beenhakker N, Koestler J, Bogers WM, Wagner R, Esteban M, Pantaleo G, Heeney JL, Jacobs BL, Melief CJ.

J Gen Virol. 2015 Jun;96(Pt 6):1478-83. doi: 10.1099/vir.0.000074. Epub 2015 Feb 9.

PMID:
25667320
14.

Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.

Verstrepen BE, Boonstra A, Koopman G.

World J Hepatol. 2015 Jan 27;7(1):53-69. doi: 10.4254/wjh.v7.i1.53. Review.

15.

Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.

Bogers WM, Oostermeijer H, Mooij P, Koopman G, Verschoor EJ, Davis D, Ulmer JB, Brito LA, Cu Y, Banerjee K, Otten GR, Burke B, Dey A, Heeney JL, Shen X, Tomaras GD, Labranche C, Montefiori DC, Liao HX, Haynes B, Geall AJ, Barnett SW.

J Infect Dis. 2015 Mar 15;211(6):947-55. doi: 10.1093/infdis/jiu522. Epub 2014 Sep 18.

16.

Strong vaccine-induced CD8 T-cell responses have cytolytic function in a chimpanzee clearing HCV infection.

Verstrepen BE, Verschoor EJ, Fagrouch ZC, Mooij P, de Groot NG, Bontrop RE, Bogers WM, Heeney JL, Koopman G.

PLoS One. 2014 Apr 16;9(4):e95103. doi: 10.1371/journal.pone.0095103. eCollection 2014.

17.

DNA/long peptide vaccination against conserved regions of SIV induces partial protection against SIVmac251 challenge.

Koopman G, Beenhakker N, Nieuwenhuis I, Doxiadis G, Mooij P, Drijfhout JW, Koestler J, Hanke T, Fagrouch Z, Verschoor EJ, Bontrop RE, Wagner R, Bogers WM, Melief CJ.

AIDS. 2013 Nov 28;27(18):2841-51. doi: 10.1097/QAD.0000000000000047.

PMID:
24105029
18.

Whole blood stimulation with Toll-like receptor (TLR)-7/8 and TLR-9 agonists induces interleukin-12p40 expression in plasmacytoid dendritic cells in rhesus macaques but not in humans.

Koopman G, Beenhakker N, Burm S, Bouwhuis O, Bajramovic J, Sommandas V, Mudde G, Mooij P, 't Hart BA, Bogers WM.

Clin Exp Immunol. 2013 Oct;174(1):161-71. doi: 10.1111/cei.12155.

19.

Transgenic fluorescent Plasmodium cynomolgi liver stages enable live imaging and purification of Malaria hypnozoite-forms.

Voorberg-van der Wel A, Zeeman AM, van Amsterdam SM, van den Berg A, Klooster EJ, Iwanaga S, Janse CJ, van Gemert GJ, Sauerwein R, Beenhakker N, Koopman G, Thomas AW, Kocken CH.

PLoS One. 2013;8(1):e54888. doi: 10.1371/journal.pone.0054888. Epub 2013 Jan 24.

20.

Chronic autoimmune-mediated inflammation: a senescent immune response to injury.

't Hart BA, Chalan P, Koopman G, Boots AM.

Drug Discov Today. 2013 Apr;18(7-8):372-9. doi: 10.1016/j.drudis.2012.11.010. Epub 2012 Nov 26. Review.

PMID:
23195330
21.

Evaluation of IL-28B polymorphisms and serum IP-10 in hepatitis C infected chimpanzees.

Verstrepen BE, de Groot NG, Groothuismink ZM, Verschoor EJ, de Groen RA, Bogers WM, Janssen HL, Mooij P, Bontrop RE, Koopman G, Boonstra A.

PLoS One. 2012;7(10):e46645. doi: 10.1371/journal.pone.0046645. Epub 2012 Oct 30.

22.

Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studies.

Donaldson MM, Kao SF, Eslamizar L, Gee C, Koopman G, Lifton M, Schmitz JE, Sylwester AW, Wilson A, Hawkins N, Self SG, Roederer M, Foulds KE.

J Immunol Methods. 2012 Dec 14;386(1-2):10-21. doi: 10.1016/j.jim.2012.08.011. Epub 2012 Aug 28.

23.

Targeted delivery of CpG ODN to CD32 on human and monkey plasmacytoid dendritic cells augments IFNα secretion.

Tel J, Beenhakker N, Koopman G, Hart B, Mudde GC, de Vries IJ.

Immunobiology. 2012 Oct;217(10):1017-24. doi: 10.1016/j.imbio.2012.01.016. Epub 2012 Jan 24.

PMID:
22349518
24.

Immunization with apoptotic pseudovirus transduced cells induces both cellular and humoral responses: a proof of concept study in macaques.

Koopman G, Beenhakker N, Hofman S, Walther-Jallow L, Mäkitalo B, Mooij P, Anderson J, Verschoor E, Bogers WM, Heeney JL, Spetz AL.

Vaccine. 2012 Mar 28;30(15):2523-34. doi: 10.1016/j.vaccine.2012.01.082. Epub 2012 Feb 5.

PMID:
22314133
25.

TRIM5 allelic polymorphism in macaque species/populations of different geographic origins: its impact on SIV vaccine studies.

de Groot NG, Heijmans CM, Koopman G, Verschoor EJ, Bogers WM, Bontrop RE.

Tissue Antigens. 2011 Oct;78(4):256-62. doi: 10.1111/j.1399-0039.2011.01768.x.

PMID:
21929574
26.

Herpesvirus saimiri infection of rhesus macaques: a model for acute rhadinovirus-induced t-cell transformation and oncogenesis.

Rosenwirth B, Kondova I, Niphuis H, Greenwood EJ, Schmidt F, Verschoor EJ, Wittmann S, Heeney JL, Bogers WM, Fickenscher H, Koopman G.

J Med Virol. 2011 Nov;83(11):1938-50. doi: 10.1002/jmv.22197.

PMID:
21915869
27.

Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies.

Verstrepen BE, Depla E, Rollier CS, Mares G, Drexhage JA, Priem S, Verschoor EJ, Koopman G, Granier C, Dreux M, Cosset FL, Maertens G, Heeney JL.

J Infect Dis. 2011 Sep 15;204(6):837-44. doi: 10.1093/infdis/jir423.

28.

No difference in Gag and Env immune-response profiles between vaccinated and non-vaccinated rhesus macaques that control immunodeficiency virus replication.

Nieuwenhuis I, Beenhakker N, Bogers WM, Otting N, Bontrop RE, Dubois P, Mooij P, Heeney JL, Koopman G.

J Gen Virol. 2010 Dec;91(Pt 12):2974-84. doi: 10.1099/vir.0.022772-0. Epub 2010 Sep 8.

PMID:
20826621
29.

CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection.

Rutjens E, Mazza S, Biassoni R, Koopman G, Ugolotti E, Fogli M, Dubbes R, Costa P, Mingari MC, Greenwood EJ, Moretta L, De Maria A, Heeney JL.

Eur J Immunol. 2010 May;40(5):1440-50. doi: 10.1002/eji.200940062. Erratum in: Eur J Immunol. 2010 Jun;40(6):1819. DeMaria, Andrea [corrected to De Maria, Andrea].

30.

A monoclonal antibody selection for immunohistochemical examination of lymphoid tissues from non-human primates.

Kap YS, van Meurs M, van Driel N, Koopman G, Melief MJ, Brok HP, Laman JD, 't Hart BA.

J Histochem Cytochem. 2009 Dec;57(12):1159-67. doi: 10.1369/jhc.2009.954123. Epub 2009 Sep 3.

31.

Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodeficiency virus strain 89.6p-infected macaques.

Koopman G, Mortier D, Hofman S, Koutsoukos M, Bogers WM, Wahren B, Voss G, Heeney JL.

J Gen Virol. 2009 Apr;90(Pt 4):915-26. doi: 10.1099/vir.2008.006148-0. Epub 2009 Feb 17.

PMID:
19223489
32.

NKp44 expression, phylogenesis and function in non-human primate NK cells.

De Maria A, Ugolotti E, Rutjens E, Mazza S, Radic L, Faravelli A, Koopman G, Di Marco E, Costa P, Ensoli B, Cafaro A, Mingari MC, Moretta L, Heeney J, Biassoni R.

Int Immunol. 2009 Mar;21(3):245-55. doi: 10.1093/intimm/dxn144. Epub 2009 Jan 15.

33.

Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge.

Bogers WM, Davis D, Baak I, Kan E, Hofman S, Sun Y, Mortier D, Lian Y, Oostermeijer H, Fagrouch Z, Dubbes R, van der Maas M, Mooij P, Koopman G, Verschoor E, Langedijk JP, Zhao J, Brocca-Cofano E, Robert-Guroff M, Srivastava I, Barnett S, Heeney JL.

Virology. 2008 Dec 20;382(2):217-25. doi: 10.1016/j.virol.2008.09.016. Epub 2008 Oct 22.

34.

Evaluation of antigen-specific T-cell responses with a miniaturized and automated method.

Li Pira G, Ivaldi F, Dentone C, Righi E, Del Bono V, Viscoli C, Koopman G, Manca F.

Clin Vaccine Immunol. 2008 Dec;15(12):1811-8. doi: 10.1128/CVI.00322-08. Epub 2008 Oct 22.

35.

Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates.

Verstrepen BE, Bins AD, Rollier CS, Mooij P, Koopman G, Sheppard NC, Sattentau Q, Wagner R, Wolf H, Schumacher TN, Heeney JL, Haanen JB.

Vaccine. 2008 Jun 19;26(26):3346-51. doi: 10.1016/j.vaccine.2008.03.091. Epub 2008 Apr 21.

PMID:
18467010
36.

Chimpanzee CD4+ T cells are relatively insensitive to HIV-1 envelope-mediated inhibition of CD154 up-regulation.

Rutjens E, Vermeulen J, Verstrepen B, Hofman S, Prins JM, Srivastava I, Heeney JL, Koopman G.

Eur J Immunol. 2008 Apr;38(4):1164-72. doi: 10.1002/eji.200737792.

37.

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic.

Corbett M, Bogers WM, Heeney JL, Gerber S, Genin C, Didierlaurent A, Oostermeijer H, Dubbes R, Braskamp G, Lerondel S, Gomez CE, Esteban M, Wagner R, Kondova I, Mooij P, Balla-Jhagjhoorsingh S, Beenhakker N, Koopman G, van der Burg S, Kraehenbuhl JP, Le Pape A.

Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2046-51. doi: 10.1073/pnas.0705191105. Epub 2008 Feb 11.

38.

Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination.

Koopman G, Mortier D, Hofman S, Mathy N, Koutsoukos M, Ertl P, Overend P, van Wely C, Thomsen LL, Wahren B, Voss G, Heeney JL.

J Gen Virol. 2008 Feb;89(Pt 2):540-53. doi: 10.1099/vir.0.83384-0.

PMID:
18198386
39.

Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates.

Mooij P, Balla-Jhagjhoorsingh SS, Koopman G, Beenhakker N, van Haaften P, Baak I, Nieuwenhuis IG, Kondova I, Wagner R, Wolf H, Gómez CE, Nájera JL, Jiménez V, Esteban M, Heeney JL.

J Virol. 2008 Mar;82(6):2975-88. doi: 10.1128/JVI.02216-07. Epub 2008 Jan 9.

40.

Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques.

Koopman G, Bogers WM, van Gils M, Koornstra W, Barnett S, Morein B, Lehner T, Heeney JL.

J Med Virol. 2007 May;79(5):474-82.

PMID:
17385685
41.

Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals.

Rutjens E, Mazza S, Biassoni R, Koopman G, Radic L, Fogli M, Costa P, Mingari MC, Moretta L, Heeney J, De Maria A.

J Immunol. 2007 Feb 1;178(3):1702-12. Erratum in: J Immunol. 2007 Jul 15;179(2):1389.

42.

Helper function of cytolytic lymphocytes: switching roles in the immune response.

Li Pira G, Ivaldi F, Bottone L, Koopman G, Manca F.

Eur J Immunol. 2007 Jan;37(1):66-77.

43.

Human naive CD4 T-cell clones specific for HIV envelope persist for years in vivo in the absence of antigenic challenge.

Li Pira G, Bottone L, Ivaldi F, Del Galdo F, Papa F, Accolla R, Koopman G, Abbate G, De Berardinis P, D'Apice L, De Palma R, Manca F.

J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):132-9.

PMID:
16186729
44.
45.

Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection.

Biassoni R, Fogli M, Cantoni C, Costa P, Conte R, Koopman G, Cafaro A, Ensoli B, Moretta A, Moretta L, De Maria A.

J Immunol. 2005 May 1;174(9):5695-705.

46.

Direct inoculation of simian immunodeficiency virus from sooty mangabeys in black mangabeys (Lophocebus aterrimus): first evidence of AIDS in a heterologous African species and different pathologic outcomes of experimental infection.

Apetrei C, Gormus B, Pandrea I, Metzger M, ten Haaft P, Martin LN, Bohm R, Alvarez X, Koopman G, Murphey-Corb M, Veazey RS, Lackner AA, Baskin G, Heeney J, Marx PA.

J Virol. 2004 Nov;78(21):11506-18.

47.

Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens.

Koopman G, Mortier D, Hofman S, Niphuis H, Fagrouch Z, Norley S, Sutter G, Liljeström P, Heeney JL.

J Gen Virol. 2004 Oct;85(Pt 10):2915-24.

PMID:
15448353
48.

Increase in plasmacytoid and myeloid dendritic cells by progenipoietin-1, a chimeric Flt-3 and G-CSF receptor agonist, in SIV-Infected rhesus macaques.

Koopman G, Niphuis H, Haaksma AG, Farese AM, Casey DB, Kahn LE, Mann D, MacVittie TJ, Woulfe SL, Heeney JL.

Hum Immunol. 2004 Apr;65(4):303-16.

PMID:
15120185
49.

Long-term persistence of HIV-1 vaccine-induced CD4+CD45RA-CD62L-CCR7- memory T-helper cells.

Balla-Jhagjhoorsingh SS, Koopman G, Mooij P, Koornstra W, McCormack S, Weber J, Pantaleo G, Heeney JL.

AIDS. 2004 Apr 9;18(6):837-48.

PMID:
15060431
50.

Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment.

Rollier C, Drexhage JA, Verstrepen BE, Verschoor EJ, Bontrop RE, Koopman G, Heeney JL.

Hepatology. 2003 Oct;38(4):851-8.

PMID:
14512872

Supplemental Content

Loading ...
Support Center